King's Foot and Ankle Unit, King's College Hospital NHS Foundation Trust, London, United Kingdom.
Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
J Bone Joint Surg Am. 2021 Jul 7;103(13):1203-1211. doi: 10.2106/JBJS.20.01178.
There is interest in hallux valgus deformity correction using internal fixation with the minimally invasive chevron and Akin osteotomies (MICA) technique. The objective of this study was to assess the correction measured on postoperative radiographs and clinical outcomes, using validated outcome measures, at 2 years following third-generation MICA.
This is a prospective single-surgeon case series of 333 consecutive feet that underwent MICA surgery between July 2014 and April 2018. The primary clinical outcome measures included the Manchester-Oxford Foot Questionnaire (MOXFQ), EuroQol-5 Dimensions-5 Level (EQ-5D-5L) Index, EuroQol-visual analogue scale (EQ-VAS), and a VAS for pain (VAS-pain). Secondary outcome measures included radiographic parameters and complication rates.
Preoperative and 2-year postoperative patient-reported outcome measures (PROMs) were collected for 292 feet (87.7%). At a minimum 2-year follow-up, the MOXFQ scores (mean ± standard deviation [SD]) had improved in each domain-i.e., reduced from 44.5 ± 21.0 preoperatively to 9.4 ± 15.8 postoperatively for pain (p < 0.001), from 38.7 ± 23.4 to 6.5 ± 14.6 for walking and standing (p < 0.001), and from 48.0 ± 22.3 to 6.6 ± 13.5 for social interaction (p < 0.001). The VAS-pain score improved from 31.4 ± 22.7 preoperatively to 8.4 ± 16.4 at the 2-year follow-up (p < 0.001), the 1-2 intermetatarsal angle was reduced from 15.3° ± 3.6° preoperatively to 5.7° ± 3.2° at the 2-year follow-up (p < 0.001), and the hallux valgus angle was reduced from 32.9° ± 10.2° to 8.7° ± 5.2° (p < 0.001).
The third-generation MICA provided significant improvement in clinical outcome measures at the 2-year follow-up and can be successfully used for correction of a range of hallux valgus deformities with a low rate of symptomatic recurrence.
Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
人们对使用微创 Chevron 和 Akin 截骨术(MICA)的内置物矫正拇外翻畸形很感兴趣。本研究的目的是使用经过验证的结果测量方法,在第三代 MICA 治疗后 2 年评估术后 X 线片上的矫正情况和临床结果。
这是一项前瞻性的单外科医生病例系列研究,共纳入 2014 年 7 月至 2018 年 4 月期间接受 MICA 手术的 333 例连续足部。主要临床结果测量指标包括曼彻斯特-牛津足部问卷(MOXFQ)、欧洲五维健康量表 5 维度 5 水平(EQ-5D-5L)指数、欧洲五维健康量表视觉模拟量表(EQ-VAS)和疼痛视觉模拟量表(VAS-pain)。次要结果测量指标包括影像学参数和并发症发生率。
共收集了 292 只脚(87.7%)的术前和 2 年术后患者报告的结果测量(PROM)。在至少 2 年的随访中,MOXFQ 评分(平均值±标准差[SD])在每个领域均有所改善,即疼痛从术前的 44.5±21.0 降低至术后的 9.4±15.8(p<0.001),从术前的 38.7±23.4 降低至术后的 6.5±14.6(p<0.001),从术前的 48.0±22.3 降低至术后的 6.6±13.5(p<0.001)。VAS-pain 评分从术前的 31.4±22.7 降低至术后 2 年的 8.4±16.4(p<0.001),1-2 跖骨间角从术前的 15.3°±3.6°降低至术后 2 年的 5.7°±3.2°(p<0.001),拇外翻角从术前的 32.9°±10.2°降低至术后的 8.7°±5.2°(p<0.001)。
第三代 MICA 在 2 年随访时提供了临床结果测量的显著改善,可成功用于治疗一系列拇外翻畸形,且症状复发率低。
治疗 IV 级。有关证据水平的完整描述,请参阅作者说明。